Residential vs. Intensive Outpatient Prison-based Treatment

住院治疗与强化门诊监狱治疗

• 批准号: 7848101
• 负责人: WILLIAM M BURDON
• 金额: $ 35.54万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-30 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7848101
• 关键词: Behavior Therapy; California; Client; Clinical effectiveness; Cognitive; Collaborations; Criminal Justice; Databases; Drug abuse; Drug usage; Effectiveness; Empirical Research; Female; Health Personnel; Health Services Research; Illicit Drugs; Institution; Interview; Lead; Legal; Length; Letters; Modality; Oregon; Outcome; Outpatients; Participant; Pharmaceutical Preparations; Policy Maker; Prisoner; Prisons; Process; Provider; Randomized; Relative (related person); Reporting; Research; Research Design; Research Personnel; Residential Treatment; Resource Allocation; Resources; Risk; Services; Severities; Substance abuse problem; System; Therapeutic community technique; Time; Treatment Effectiveness; Washington; Work; alternative treatment; base; cost; cost effective; cost effectiveness; design; drug testing; effective therapy; experience; follow-up; indium arsenide; male; offender; policy implication; programs; response; substance abuse treatment; treatment program

DESCRIPTION (provided by applicant): The UCLA Integrated Substance Abuse Programs (ISAP), in collaborations with the Washington State Department of Corrections (WSDOC) and CiviGenics, Inc., is proposing a 5-year study to assess (1) the differential clinical effectiveness and cost-effectiveness of long-term residential treatment versus intensive outpatient treatment in a prison-based treatment setting and (2) to determine whether either treatment modality is more effective for drug-involved offenders matched to either treatment modality (e.g., based on risk level and/or substance abuse severity). Research has demonstrated the effectiveness of both therapeutic community and less intensive cognitive-behavioral treatment approaches to treating drug involved offenders in prison settings. However, these two treatment approaches differ in terms of duration and intensity of treatment services, and no empirical research has examined the differential effectiveness and cost-effectiveness of these two treatment approaches as they pertain to drug-involved offenders in prison. Eight hundred inmates (600 males and 200 females) will be randomly assigned to 9-month long-term residential (LTR) or 12-week intensive outpatient (IOP) prison-based treatment. Study participants will be assessed in face-to-face interviews at the time of recruitment (baseline), immediately prior to discharge from the treatment programs and release from prison (pre-release), and at 12-months following their release from prison and completion of in-prison treatment. In addition, WSDOC will provide records-based data on post-release treatment participation, illicit drug use (i.e., results of drug tests), and return-to-custody rates during the follow-up period. The study has the following primary aims: (1) Examine the differential effectiveness of LTR versus IOP treatment in a prison-based treatment setting. (2) Determine whether prison-based LTR or IOP treatment is more effective for drug-involved offenders who are appropriately matched to LTR or IOP treatment (e.g., based on risk level, substance abuse severity). (3) Examine the cost-effectiveness of LTR versus IOP treatment in a prison-based treatment setting. Correction departments are increasingly providing prison-based treatment to drug-using offenders. The results of this study will have potentially significant financial and policy implication to state legislatures, policy-makers, and corrections departments in terms of how increasingly limited financial resources are allocated to the treatment of drug-involved offenders.

描述（由申请人提供）： 加州大学洛杉矶分校综合药物滥用计划（ISAP）与华盛顿州惩教局（WSDOC）和Civigenics，Inc。合作，正在提出一项为期5年的研究，以评估（1）长期临床有效性和长期成本效益 - 在基于监狱的治疗环境中的期限居住治疗与强化门诊治疗，（2）确定两种治疗方式是否对涉及任何一种治疗方式的涉及药物的罪犯更有效（例如，基于风险水平和/或药物滥用严重性）。研究表明，治疗社区和较少密集的认知行为治疗方法的有效性，以治疗监狱环境中涉及罪犯的毒品。但是，这两种治疗方法在治疗服务的持续时间和强度方面有所不同，并且没有经验研究研究了这两种治疗方法的差异效果和成本效益，因为它们与监狱中的毒品涉及罪犯有关。八百名囚犯（600名男性和200名女性）将随机分配为9个月的长期住宅（LTR）或12周的强化门诊病人（IOP）监狱治疗。研究参与者将在招募时（基线），直接从治疗计划出院并从监狱中释放（预发行）以及从监狱释放和监狱内治疗的完成。此外，WSDOC将提供有关释放后治疗参与，非法药物使用（即药物测试结果）以及在随访期内重返监护率的基于记录的数据。该研究具有以下主要目的：（1）在基于监狱的治疗环境中检查LTR与IOP治疗的差异效果。 （2）确定基于监狱的LTR或IOP治疗对于与LTR或IOP治疗适当匹配的毒品犯罪者（例如，基于风险水平，药物滥用严重程度）是否更有效。 （3）在基于监狱的治疗环境中检查LTR与IOP治疗的成本效益。惩教部门越来越多地为吸毒罪犯提供基于监狱的待遇。这项研究的结果将对州立法机关，政策制定者和惩教部门具有潜在的重大财务和政策影响，即如何将财政资源分配给涉及毒品涉及的罪犯的待遇。